BioSyntech
(OTC) BSYI
This security has been delisted. This page is retained for historical reference.
BSYI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowBSYI Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-271%
Net Income Margin
-317%
Return on Equity
5%
Return on Capital
2%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
CA$24.80K
Operating Income
-CA$11.03M
EBITDA
-CA$10.62M
Operating Cash Flow
-CA$9.57M
Capital Expenditure
-CA$232.64K
Free Cash Flow
-CA$9.81M
Cash & ST Invst.
CA$4.94M
Total Debt
CA$12.08M
BioSyntech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
CA$509.00
-89.2%
Gross Profit
-CA$409.00
-113.0%
Gross Margin
-80.35%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
-CA$3.38M
+25.4%
EBITDA
-CA$3.25M
-6.2%
Quarterly Fundamentals
Total Cash
CA$1.44M
-77.2%
Total Debt
CA$17.30M
+51.5%
Accounts Receivable
CA$1.79M
+1007.6%
Inventory
CA$32.15K
+60.6%
Long Term Debt
CA$1.49M
-30.2%
Short Term Debt
CA$15.80M
+70.4%
Return on Assets
-1.80%
N/A
Return on Invested Capital
2.34%
N/A
Free Cash Flow
-CA$1.56M
+45.1%
Operating Cash Flow
-CA$1.56M
+44.8%